CTN Bulletin logo
January 31, 2018  

NIDA Encourages Mentored Career Development Applications Using CTN Resources

SHARE ISSUE ON 

Facebook

The CTN provides a rich platform of scientific and clinical expertise focused on bridging the gap between the development of novel SUD treatment modalities and effective clinical delivery of these interventions to a variety of patient populations in real world settings, making this an ideal environment for qualified clinicians to further develop their independent research careers.

Because of that, NIDA is encouraging Individual Mentored Career Development K08 and K23 applications utilizing CTN resources.

CTN members are encouraged to identify and work with potential applicants who will incorporate CTN expertise and resources into their proposed research and career development plans.

Candidates for these awards must have a clinical doctoral degree. Such degrees include, but are not limited to PhD, MD, DO, DDS, DMD, OD, DC, PharmD, ND (Doctor of Naturopathy), and DVM. Individuals with other doctoral degrees in clinical disciplines such as nursing, clinical genetics, or rehabilitation are also eligible. Clinicians specializing in internal, family, and/or emergency medicine; infectious disease/HIV; medical genetics; psychiatry; addiction medicine; and bioinformatics are underrepresented in substance use disorder research and are encouraged to apply.

Applicants who choose to develop their research plans utilizing CTN resources must select a primary mentor who is a current CTN Investigator with an MD, PhD, DO, DDS/DMD degree or a nurse with a research doctoral degree. If the primary mentor is a PhD, then a secondary MD mentor with appropriate scientific expertise as required by the individual career development plan must be selected. Additional secondary mentors from CTN as well as outside of CTN are allowed as needed and encouraged.

Full Announcement: https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-001.html

CTN Trial Progress

GraphStudy results for Open Studies as of the January 30 trial Progress Report.

CTN-0064 - Linkage to HCV Care. Enrolled 113

CTN-0068 - ADAPT-2 for Methamphetamine Use Disorder. Enrolled 126

CTN-0069 - OUD in the Emergency Department. Enrolled 146

CTN-0073 - Detecting Cocaine Use Using Smart watches. Enrolled 14

Total Enrolled in all Studies: 24,505

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.



· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Webinars and Educational Materials

Pregnant? Concerned about Opioid Use? Poster for AI/AN Communities

In response to the current national opioid epidemic affecting the American Indian/Alaska Native (AI/AN) families, collaborators from NIDA, NIAAA, IHS, NIDA research grantees, and health providers in AI/AN communities met in May 2017 to identify issues associated with opioid misuse in Native communities.

One specific issue raised during that meeting was the need to develop prevention materials specifically aimed at reducing opioid misuse among Native American pregnant women.

In response, this full-color prevention poster provides a reminder of traditional ways and suggestions on how to get help for opioid misuse.

Find a downloadable PDF version here. For high quality printed copies, contact Carmen Rosa at crosa@nida.nih.gov.

CTN Webinar: Developing and Negotiating Study Budgets and Contracts, Feb. 8, 12pm (ET)

Join the NIDA Clinical Coordinating Center at the Emmes Corporation on February 8, 2018 from 12-3pm (ET) for their next webinar, "Developing and Negotiating Study Budgets and Contracts." Negotiating study contracts and budgets is critical for the future success of the clinical research site. This web seminar provides strategic skills and best practices for contract negotiations and budget development. Learners will also review and practice the art of negotiation. Read more and register here. . .

Video: Tackling the Ohio Opioid Crisis: Harnessing the Power of Science to Break the Cycle

The Ohio Valley Node hosted CTN Director Dr. Betty Tai and NIDA senior advisor Geoffrey Laredo on November 27-28 to visit OVN offices and associated treatment programs at the University of Cincinnati. The visit included a public symposium on Tackling the Ohio Opioid Crisis: Harnessing the Power of Science to Break the Cycle, for which Dr. Tai presented the keynote address "Collision Of PAIN & OPIOID Epidemics: Challenges & Solutions."

Over 400 attendees received information on efforts by local legislative bodies, state-level policy makers, academic health systems, providers, and researchers to more effectively address the current opioid crisis in Ohio in the OVN! A video of this event is now available! Watch online at http://ctndisseminationlibrary.org/display/1298.htm


· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

News from the Nodes

Ohio Valley

A new study led by Dr. LaTrice Montgomery at the University of Cincinnati (UC) College of Medicine (Ohio Valley Node) will look at blunt use among African-American young adults. Dr. Montgomery will use social media, specifically Twitter, to engage this target group in discussions on blunt use and the health hazards. This will be the first study to develop and assess a treatment intervention specifically for blunt use. While existing studies may look at tobacco or marijuana use separately, there is little data available on the dual use of tobacco and marijuana via blunts.

Dr. Montgomery, a prior trainee in the Learning for Early Careers in Addiction and Diversity (LEAD) program, will use a NIDA Mentored Patient-Oriented Research Career Development Award (K23) to focus on the development and evaluation of a digital health intervention for African-American young adult blunt smokers. The project will begin with individual interviews with young adults to gain a stronger understanding of cultural norms and patterns of blunt use and gauge attitudes toward social media engagement. Following that, Dr. Montgomery will develop a small-scale randomized clinical trial of a Twitter-based intervention, engaging groups in discussion on the social media channel to promote the reduction of blunt smoking among African-American young adults.

If found to be a feasible approach Dr. Montgomery says, "A Twitter-based intervention may provide an accessible and effective way to reduce blunt smoking and thereby decrease morbidity and mortality rates associated with marijuana and tobacco co-use."

New England Consortium

Harvard Medical School/McLean Hospital -- Addictions 2018 Conference

The New England Consortium Node is pleased to announce the upcoming Addictions 2018 Conference to be held May 18-19, 2018 in Cambridge, Massachusetts.

The conference, sponsored by Harvard Medical School and McLean Hospital, is for Physicians, Psychologists, Addiction Counselors, Mental Health Professionals, Nurses, Nurse Practitioners, and Social Workers. Roger Weiss, M.D., and Shelly Greenfield, M.D., M.P.H. are program directors of the conference.

Presentations will cover topics such as effective treatments for opioid use disorders, research on marijuana, stress and addictions, specialized approaches for addictions in women, anxiety and insomnia with addiction, adolescents and addiction, best practice approaches for working with veterans and first responders, and mobile technologies in addictions.

Faculty presenters from the New England Consortium Node include Roger D. Weiss, M.D., Shelly F. Greenfield, M.D., M.P.H., Hilary Connery, M.D., Ph.D., and R. Kathryn McHugh, Ph.D.

For more information, including a course brochure and registration instructions, go to the following site.
http://cmeregistration.hms.harvard.edu/events/addictions-2018/event-summary-c297aa35ac4a4854815889166e703a0b.aspx?RefID=cmecatalog



Northeast Node

This past September, Dartmouth-Hitchcock Medical Center’s (DHMC; Lebanon, NH) Division of Obstetrics and Gynecology (OB/GYN) implemented the "Purple Pod" -- a division of OB/GYN that provides weekly clinics for patients with pregnancies complicated by substance use disorders (SUDs) who are receiving medication-assisted treatment (MAT) from providers outside of the hospital’s "Moms in Recovery" program.

Northeast Node Core Investigator Daisy Goodman, DNP, MPH, CNM, WHNP-BC, OB/GYN Dr. Timothy J. Fisher, MD, MS, and three second-year residents Tara Higgins, Meredith Pavicic, and Zachary Spalding, noticed that pregnant patients receiving MAT from providers outside of DHMC were not receiving other wrap-around services that mothers in their own perinatal SUD treatment program were receiving. The Purple Pod was launched to address this gap.

DHMC’s OB/GYN department provides treatment in "pods" to allow for more continuity of care for pregnant patients across the length of their pregnancy.

Once implemented, Children’s Hospital at Dartmouth (CHaD) Pediatrician Steve Chapman, MD (also a Northeast Node Core Investigator), began a similar pod in the pediatrics department, caring for babies whose parents are in treatment for SUDs. The pod in pediatrics continues wrap-around services from OB/GYN after birth.

"They were getting high-quality, routine obstetric care from us, but without a lot of the education to help prepare them for coming to the hospital and understand how best to care for their babies. To address that, we decided to develop a mini clinic. One of the things we help them understand is that their babies need to be observed in the hospital for four days after they are born and may need to be treated for neonatal abstinence syndrome (NAS). And we make sure they have all the social supports they need," Goodman said.

As part of this broader initiative in New Hampshire, the second-year OB/GYN resident curriculum focuses on obtaining a buprenorphine waiver and caring for pregnant women with SUDs.

You can read more about the Purple Pod on DHMC’s website.

New from the ATTC

ATTC Messenger for January 2018: ATTC Network and AMERSA Announce New Partnership by Maureen Fitzgerald.

From the ATTC/NIATx Service Improvement Blog:

SoberBowl II: Stealth Recovery Advocacy

The Opioid Crisis: Community is Key to Addressing the Epidemic (Holly Ireland, LCSW-C, Central East ATTC)

New Year -- New Web Accessibility Laws (Kendra Barker, MEd, Instructional Designer)

 


· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

New in the CTN Dissemination Library

Exploring Longitudinal Course and Treatment-Baseline Severity Interactions in Secondary Outcomes of Smoking Cessation Treatment in Individuals with Attention-Deficint Hyperactivity Disorder. Luo SX, et al. American Journal of Drug and Alcohol Abuse 2018 (in press).

Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users: A Latent Class Analysis. Yee K, et al. AIDS and Behavior 2018 (in press).

Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): Results from the STRIDE (CTN-0037) Study. Tombello JM, et al. Journal of Clinical Psychiatry 2018;79(1):17m11707.

Incremental Validity of Estimate Cannabis Grams as a Predictor of Problems and Cannabinoid Biomarkers: Evidence from a Clinical Trial. Tomko RL, et al. Drug and Alcohol Dependence 2018;182:1-7 (in press).


· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Also of Interest

Early Stage Investigator Scientific Paper Competition

The NIH Office of Behavioral and Social Sciences Research will host the 11th NIH Matilda White Riley Behavioral and Social Sciences Honors on Thursday, May 31, 2018 from 8:00 am to 12 noon E.T. on the NIH main campus in Bethesda, MD (Wilson Hall, building 1). The festival is free and open to the public. Free registration for this event is required. This meeting will not be live webcast. Please register to attend this meeting in person.

The submission period is now open for the Early Stage Investigators (ESI, within 10 years of their terminal degree) paper competition. ESIs are encouraged to submit one article published, or accepted and in-press, between January 1, 2017 and December 31, 2017 that involves original research published in a peer-reviewed journal in which the ESI is the first author. Find out more about this competition here. . .

Upcoming Webinars and Events

CTN Webinar: Developing Clinical Study Budgets for Sponsors - March 16, 2018, 1-3pm.

CTN Webinar: For Clinical Trial Investigators:
Principal Investigator Oversight & Appropriate Task Delegation - March 15, 2018, 11am-12:30pm.

Email CTNtraining@emmes.com to register for either of the above!

Conferences in February 2018: (find more upcoming conferences here!)

 

 

     

Published by the CTN Dissemination Library of the Pacific Northwest Node
Alcohol & Drug Abuse Institute, University of Washington

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol & Drug Abuse Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

Unsubscribe | Subscribe

Copyright (C) 2016 Alcohol and Drug Abuse Institute. All rights reserved.